Eric Malzone: Hey friends, welcome to the Future of Fitness, a top-rated fitness and wellness industry podcast for over five years and running. I'm your host, Eric Malzone, and I have the honor of talking to entrepreneurs, innovators, and cutting-edge technology experts within the extremely fast-paced industries of fitness, wellness, and health sciences. If you like the show, we'd love it if you took three minutes of your day to leave us a nice supporter review wherever you consume your podcast. If you're interested in staying up to date with the future of fitness, go to futurofitness.co to subscribe and get weekly summaries dropped into your inbox. Now onto the show.
Eric Malzone: Spanning over 4,000 clients in 40 plus countries, TeamUp has a vast global network with its roots right here in North America. Whether it's AI, new features, new partnerships, and new markets, TeamUp's sites are set on raising the bar of the industry to enable their customers to perform and operate at the highest level locally, nationally, and overseas. Powered by the most reliable APIs on the market, you can deliver premium customer experiences and scale your fitness enterprise with the strongest technological infrastructure our industry has to offer. Empower your staff, engage your members, and unlock your next chapter of growth with software design for you. Learn more at goteamup.com. That is G-O-T-E-A-M-U-P.com. Today's episode of The Future of Fitness is proudly brought to you by E-Gym, a vertically integrated market leader in the
Eric Malzone: fitness and health industry with an incredible vision, transforming healthcare from repair to prevention. I've been a huge fan of EGM's team and technology for years now, and I can tell you that their commitment to innovation is unparalleled within our industry. Here's what makes E-Gym so special. They partner with companies to improve employee health by providing access to fitness and health facilities. Then they equip those facilities with cutting-edge smart gym equipment and digital solutions. The benefits are clear. Companies see reduced healthcare costs and increased productivity, while fitness facilities benefit from a growing, engaged membership base. What really excites me is EGI's smart fitness ecosystem. By combining their strength equipment with AI-powered software and their corporate wellness platform Wellpass, they are leading the shift to proactive preventative health. This isn't just AI for show. This is the real deal. If you're interested in learning more about eGym
Eric Malzone: and how they're transforming healthcare through exercise, visit eGym.com. That is egym.com. Nasheen Hushemi. Welcome to the Future of Fitness. How are you today?
I'm doing great. Thanks for having me.
Eric Malzone: Yeah. This is super interesting. You know, I as I was telling you, I've I've been a connoisseur of wearables since they really kind of got going. And I work with a couple different startups that feed data through various sources. And uh what you're doing at January AI is revolutionary for a lot of different reasons. Um, number one, the lack of needing CGMs, um, so continuous glucose monitors, but also the path you're you're paving with AI and improved health outcomes and metabolic disease. Uh, it's super exciting. And this is the kind of thing I think when people dream about what AI can be uh in a positive note. This is the type of thing that they hope for. So very exciting. Um let's start with this, if you don't mind, uh Shin. Just give us a little of your background on how you got to be at the helm at January AI.
Sure. Yeah, I started my career in technology back in a long time ago, 1985. Um, actually 1984 is when I graduated from college and um briefly um worked at a semicoder company before landing at Oracle for the following 10 years. So my life has been about software. And um, and then in um after Oracle, I had a very brief time off. I had I had worked famously uh impossible um hours, uh 18-hour days, uh seven years straight, and then 14-hour days, three years straight. Um and so um yeah, I had a little brief moment when when I went around the world. And then I landed at a uh at a uh what at the time we called a dot-com uh in the mid-90s, and was there um uh for a year, company got sold, and I went on and um had a couple
of kids and started a couple of foundations, and then in 2013 decided to go back to the dark side and uh ended up starting my own company in 2017.
Eric Malzone: Awesome. Uh and that in is that January or when did it be? Okay.
That's January. Yeah, in 2013 I went. Um I went into uh my family, uh my family office has invested in a lot of small companies, and I started sort of going around and helping entrepreneurs that we had invested in. And um two or three years later I decided, you know, I want to I want to do this myself. I'm gonna roll up my sleeves and and start something from scratch from a clean sheet of paper. And so um at the time I was dealing with some um with a chronic condition myself, and then both of my parents were having um medical problems. My uh my father was diagnosed late, he he passed away, um, and my mother he had already passed away. I was I was like uh looking for answers because he was such a health nut, but um I've spoken extensively about um the unfairness and the you
know the the crazy thing where you can live your life so well, but then you know not be told about something that happens until it's too late. Um and then my mom was misdiagnosed, she was diagnosed as having asthma, she had heart disease, and she almost died. And then she we we basically the kids figured it out, and we kept her alive. Usually life's expectancy after diagnosis for heart disease about five years for height failure heart failure, and for her, we kept her alive uh another 10 years, so about 15 years, um, by managing her diet 100%, just having uh you know no more than two grams of salt a day, which is really impossible, especially my mom was a foodie and that was really, really hard. Yeah, so I ended up um on this health um search and came across Mike Snyder, my co-founder, who is well known for a field called multiomics, which is the idea of looking at your health from various angles, like your microbiome, like your
genome, uh, looking at it from your blood test, your wearable data, um, and a number of other data like what's your behavior online, what you know, you can you can actually figure out. So multi-omics can very accurately and very early detect what might happen to you later in the future. And um where you know traditional medicine can only really tell you after you've been showing symptoms already. And with multiomics, no symptoms shown, you know, by looking at these various pieces of the puzzle, you can put together what is likely going to happen to this person. So I became very interested in this, found Mike Snyder. We decided to start a company together. He has type 2 diabetes, and he's obsessed with wearables, and that's kind of how we ended up in this direction.
Eric Malzone: Yeah, multi-omics. Okay. That's uh yeah, it's a new term for me. I'm already learning. We're only five minutes in, I'm already learning, and I love this. So, okay, you started in in 2017, is that what you said? Um that's early.
That's when you started, yeah.
Eric Malzone: Yeah, yeah, that's when I started my podcast. Yeah, good memory. Um that's early. I mean, when you talk about like the discussion around metabolic disease, um artificial intelligence, most of this really wasn't in nomenclature, right? It wasn't around. So, how did you start to identify that this may be a future path?
Part of it is that part of it, it's it's multiple things. One is that um I'm an obsessive researcher. So well before I fell into metabolic and AI, I fell into just healthcare as a sector was going to explode. And I got that, I mean, I started researching in 2015, between 2015 and 2017, I looked at every Series B deal that had been done, and every I read everything you can imagine. I mean, I'm a very, very, very thorough researcher. And so I had already, I was already landing on health, but health and health care was really a sad story. Nobody nobody wanted to invest in you know sick care, basically, right? And our thinking was that nobody wants to change their behavior. Nobody wants, you know, behavior change is difficult. Touching health care was like touching the plague, you know, it's just nobody wanted to do it. Um, but um, so part of it, I'm a big researcher. Part of it is um because of um
essentially the people that I happened to have found uh to find, I happened to find Mike Snyder, who was a multi-omics person, had type two, sort of led me in that direction. And the technical co-founder that I found was an AI-obsessed uh physicist, um theoretical physicist. Just so it just happened, like the sun and the moon all got actually aligned that way. And then I got lucky. That's the third factor, which is luck, which um I shouldn't say we got lucky that we got the pandemic, but I think for um the planet, I think this idea of a moment's pause of just saying, what's happening here right now? What is why are 40 percent 40% of the people who died uh from the pandemic had some kind of underlying conditions, condition? This idea that having an underlying condition is not okay, it's not something we should just live with. And you know, and um 60% of Americans have at least one chronic
condition. Um and a smaller uh 10% of the population has five chronic conditions at the same time or more. So, you know, what kind of odds are we giving ourselves? Um so but I was I am a futurist, so I could see uh very, very well. I could see AI and health coming together long before venture capitalists had practices in healthcare, long before all of this. So we started essentially working on AI and healthcare when OpenAI started its work, and it was sounded very um, it sounded very esoteric and impractical and undoable, and people are like, What are you doing? Well, I'm turning food into an asset, I'm turning food into a measured variable into in someone's health. They're like, How are you gonna do that? People people famously eat, you know, whatever the hell they want. They they have, you know,
food is something you didn't touch in 2017. People are supposed to eat whatever they want, anytime they want, however much they want, anything else. So this idea that I could sort of show you a mirror, if you will, in terms of what's happening to you metabolically, cardiometabolically, based on what you're eating, was just inconceivable at the time. But we absolutely had that vision and we were obsessed with continuous glucose monitors in 2017. Um and we thought, well, there's gotta be things we can learn at the intersection of CGMs and CGMs themselves, revolutionary, really interesting, close the loop. But CGMs and smartwatchers together, now that's really interesting. And then we quickly learned that one of the most important factors, well, the most important factor in in your metabolic health is the food you eat 100%. We proved it, we published it. It is a fact that over and above anything else, you know, people think I'll
just eat two pizzas and then I'll just work out for two hours. No, it doesn't work that way, actually. So not to confuse weight also with metabolic health and and having that sort of massive jolt of um, you know, massive kind of assault on your metabolic system if you actually ate two pizzas. Um so yeah, so that's that's kind of how we ended up here.
Eric Malzone: It's uh it's really interesting. And spending, you know, I think eight or nine years that I did in kind of in the trenches, as I would say, of working with clients. Nutrition is such a emotionally charged topic for many people, right? It's it's you know, it it like you could get, you know, there's a million jokes. You put like a you know, a carnivore guy and a and a vegan in a bar and some joke comes out of that, right? Like you it's very emotionally charged. But what I what I've loved about wearables is not just the data that you get, it's it's become an objective starting point for conversations. So if you are a practitioner or someone who's trying to guide people to a healthier lifestyle, you now have something that's not emotionally charged. It's just data, it's just information. Now you can have a real conversation about that. I feel like that's something that you guys are making more accessible to people. So, you know, as you as you started this journey in 2017, how has the product and the experience evolved into what it is now?
Yeah, yeah, I love to talk about this. So, in the beginning, of course, we were researched. So for three years we sat in research. We were still um so what we were looking at for three years were things like first of all, we used to eat, we used to actually experiment on ourselves. So eat the same breakfast nine days in a row, same amount of workout, same amount of everything, um, or eat and walk across the just the office just to see what happens. We call the prancer sizing. Any kind of movement movement lowers your blood sugar. It's incredible how sensitive this is and how important it is to do it right after you eat, not 20 minutes later, because by then your blood sugar has already spied. So it's um so we were expecting we ate guar gum, you know, we would, you know, the stuff we we did, so many things for three years, but on a machine learning level, we first we essentially started working with JIGL, glycemic index and glycemic load foods, and trying to understand if we could produce this for for
any food. Um, that was one area area of search. We another area of research for us was nutritional inference. If I look at any food, can I tell what macros does it have? And how can I do that? Um, that was another machine learning project that we did. Uh, and then we ran a clinical trial um from 2018 to 2020 where we um for over a thousand people we put CGMs on them, we put smart watches, and we looked at their behavior and we looked at the essentially the glycemic response uh of their body um to the foods they were eating. And we came up with our first paper in 2020 that we put out at the American Diabetes Association convenings, and that paper predicted someone's glucose 33 hours into the future, uh, which is incredible. You could only predict people's glucose about half an hour at that time. And it was also trained on food, so it wasn't just like I can tell you if this person's glucose is gonna go
up or down in the next 30 minutes. It was like, I'm gonna tell you what will happen to this person's glucose if they eat pizza versus apple versus versus any food. Um, and that's just crazy because none of the prediction models um were or are trained on food, only January is trained on food. Um, so basically, most of the prediction models are trained on carbs, carbs and insulin. Sort of they just tell you you can say, I'm gonna have 40 grams of carbs, they say take this much insulin. Um, that's kind of what was available. So we changed state the state of the art dramatically in 2020. And then um other people started putting out, like basically put a very thin app uh on top of a CGM and took it out as their own CGM, which is crazy because none of these companies make CGMs, they're all marketing firms, but they all kind of, you know, and the public doesn't know that, so the consumers think that you know they're all making hardware, which they don't. But they are basically app companies,
they're marketing companies that did a really good job taking um basically what already existed and made it accessible to people via telemedicine and all of that. So we said, okay, fine, we'll jump in and do that. Um now, so in 2020, we put out our first version, our V1 of our product, which was really the app we had built to run the clinical trial. So we took the app we had run to run to run the clinical trial and we put it out in the app store and we said, okay, great, we put some lipstick on it and said, let's use this. Um and we started getting you know hundreds of orders, especially because um because the the sector was very hot, other other players were like, oh, we have 250,000 people waiting, and so people would just come and get it from January, that kind of stuff. And it was it was very cool, and we had incredible clinical outcomes. Um, we had you know anecdotally, people were losing, you know, 10, 20 pounds. But also
we ended up eventually publishing on that first version of the product. We published um in NPJ Digital Medicine, which is an imprint of nature, it came out last November. So we we published what we were doing in 2020, 2021, we published it in 2023, and people had you know dramatically changed the way they were eating. They were eating fewer carbs and fewer calories, they were eating more protein, more fiber, um, with both of which help your blood sugar. And they were living more in you know, in better, a healthy timing range, and they had lost weight. So that was really exciting. But the product was clunky, and we decided it was it was also a very rigid product. It was a 90-day product because it was the mindset was still based on diabetes prevention program, which is like, oh, you know, you need to have all this content, you know, tell people you have, you know, kind of like Noom, which is very old world. It's super old world to tell people you have three tasks today,
you know, that's not how that's not how AI works. Um, so that was our vernacular. We're like, what are the best products out there? You know, Mada, Noom, all these people. Great. We'll come up with something that is task-oriented where you give people, you know, three to seven things to do in a day. One of them is read an article, one of them is like, you know, um, avoid spiking foods today or eat these many calories or whatever. So very successful, but not as cool as we thought our version two was, which was what we call an always experience. You basically came in, it was very much self-managing, you weren't told to do anything, you were just given some targets, and that's it, left on your own. And that actually was incredibly successful, more successful clinically. And we have a paper that we've submitted right now on that experience that we hope gets uh accepted. And we showed even more weight loss. So when people actually had tools and they were self-managing, weren't being told what to do. Like
uh in the old program, we had today, you know, eat your old breakfast for two or three days, then eat a keto breakfast, then eat, then you had a sugar shot, and we compared these three and we said, here's your breakfast, how much it looks, you know, and and this is how close it is, let's say to the keto versus the all-sugar. And we gave these people these experiential things. Here we weren't doing any of that, nothing. We were just saying, here, just throw on the CGM, wear your spot watch, walk around, and we can tell you how much you're fasting, how how close to bedtime you're still eating. We were giving them these counterfactuals like yesterday you ate this, but you could have you could have eaten this, or yesterday you ate this, but if you had worked, you know, you had walked 20 minutes after this, what would have happened to your blood sugar, just by just very, very hands-on, hands-off, frictionless, and we had great clinical outcomes. But this technology still was out of reach for most people, still too expensive. It's $288, and it was a tremendous amount of burden
that we were carrying on behalf of the CGM maker, because anybody who's built a business around CGM will tell you that there are a lot of problems with it. They fall off, they can be wrong. Um, sometimes you just get a bad one. Um, and so there are a lot of issues, a lot of service issues, customer service issues that really look bad on you, and also they're just inaccessible, they're just too expensive. So, our obsession was with um so um we wanted to come. With a version that could be broadly used for educational purposes. So the first time that we put out our paper, we could predict glucose while the person was wearing a CGM, but without having to eat something. So they it was while they were wearing a CGM, but they haven't eaten, you know, we trained their AI on A, B, and C, now they're eating, you know, G H I, and we could predict
their glucose. So that revolutionary, incredible. But the next stage, we were able in V2 to remove the CGM and still be able to predict for the person. And then after that, we were able to actually draw CGM curves for people as long as they kept um logging their food and wearing their smartwatch. We could still do that with fairly high accuracy. And then next thing that happened, which is our version three of our product, which is what's in the app store today, that product doesn't use a CGM at all. So if we've taken elements of the models, uh demographic elements of the models, like how old you are, your height, your weight, your gender, whether you have pre-diabetes, diabetes, you're healthy, etc., your ethnicity, and we are now extrapolating directionally correct um information for you, which we think is wonderful for educational purposes,
it's fantastic. And if you really, really want to know if you're a rice spiker versus a you know a potato spiker, throw on a CGM. But if you don't, for most people, we feel like education is what's lacking, um, and awareness and just having that on your radar, what could be happening to your blood sugar. I continue to be surprised how little people know, how little people know about nutrition and how little people know about volumes. Like I was at I was speaking at the Fortune Global Forum a couple weeks ago in New York City, and we were sitting at this table, and there were these mini desserts, like mini brownies and mini donuts. Um, six of them were almost a thousand calories. They were only a very, very small and a thousand calories, like you know, all I can eat in a day is 1300 calories because I happen to have high body fat, unfortunately. Um, that's all I can manage. So if I if I just blew a thousand of those calories by just eating those little things, just not thinking
that you know they're not they don't look low volume. So I think we all of us miscalculate just what we're doing to ourselves every day from volume perspective and from blood sugar perspective. Certainly from macros perspective, we are not really that focused on protein and fiber as much as we should be.
Eric Malzone: Awesome. So in the current edition, what's in the app store? And I believe um, from the information I have, you guys have over 100,000 users now, and it hasn't been in the app store super long, right? I mean, it's it seems to be accumulating users pretty quickly. Like, walk me through like what is the um consumer experience? What's the user experience from start to finish? Once they find the app in the app store and they download it, what happens?
Well, the first thing they do, they have to go through this onboarding process where they tell us about themselves. So, for example, what food sensitivities they have, what food allergies they have, because our recommendations are all highly, highly personalized. So if you just never want to eat abalone, you we won't give you an abalone recommendation. So a lot of it is about understanding your preferences, your dietary preferences, and understanding what you want to and not want to eat. Also, understanding your physiology, um, demographics, like we talked about.
Eric Malzone: This episode is brought to you by our good friends in Matabolic. Matabolic is a boutique franchise system built for entrepreneurs and backed by experience. Founded by former professional athletes Brandon Colin and Kirk DeWall, Matabolic blends elite training principles with a proven business model. With 36 open locations, eight new markets launching soon, and another 50 plus in development, now is the time to invest alongside a growing high-performance boutique fitness brand. Learn more at Matabolic.com. That's M-A-D-A-B-O-L-I-C.com.
And making sure you're not using insulin today, for example, we go through an onboarding process just to understand you because how can we truly personalize an experience if we don't understand sort of your current condition? And then uh you're ready to go. Once you're in the app, you can start taking pictures of anything. And I really challenge anyone here to show me a better um food scan experience than what's in January. I would love to see where it is because we benchmark everyone. We benchmark anyone. Uh, you mentioned a couple of names before we started. We benchmark everybody that you can think of, from the kings, you know, of food tracking, like MyFitnessPal, to you know, metabolic players like levels. We are absolutely the best. Uh, there's nothing better than we are. So take a picture of anything in front of you and get its macros right away, get its macros, like basically um its macro
and micronutrients, you know, carbs, all that. And then uh see the impact, see the blood glucose impact. And what comes next is counterfactuals. This is what only AI can do for you, which is um, if I ate, you know, this is basically this is your curve, but if you cut out half of the rice, this would be your curve. You cut out half of the um wheat or you know, bread, this would be uh your response. And you don't so you could play with it. Um, I think you know, when I first started way back in 2017, Chris Gardner um from Stanford University worked with us very closely. And he always said he's sort of the god of nutrition there. He said, you can't get people not to eat something. You just tell them, don't eat sugar, don't eat, don't eat flour, don't you know eat broccoli, you know, all day long and like to walk 10,000 steps, they're just not going to, and they haven't. And this sort of one size fits all doesn't work. What you can do is to try to get people to eat a little bit
more of what's good for them and a little bit less of what's not good for them, and to get them to understand that just over time. And if you can do that, you're very successful. And we we do exactly that. So if you can experiment a little bit, like you have to give up french fries completely, no, but you know, you can see the impact, you know, visually. Um, and the beauty of AI is you don't have to eat it to see the impact. Um, and that's that's the that's really the genius of of AI. And that's um not only we've been able to make that available to people who wear CGMs, but now available to people who can't afford or don't want to wear a CGM because it's invasive.
Eric Malzone: Yeah. And what's uh it's awesome. And you know, it's I think we you'll start to see the thing about human behavior change from my experience is you number one, you've got to meet people where they are, right? It's sometimes it's just a bridge too far, and that's why you know a lot of times it's very hard for people to get into the gym if they're coming off the couch, like to come in and start doing three classes a week or CrossFit or something like that. It's too far, it's too much, right? But everybody has a phone, right? Everybody knows how to use apps, so kind of meeting them in that space and educating them, and I think that's like you're starting to see this this huge decline in alcohol intake. And I have to believe that has to be due to wearables and what people are starting to see in their sleep and their HRB. So they're starting to get educated themselves through the through the data, right? So it's really it's a really cool time. Um, Nushim, what is what is the business model for you guys? Like how are how are you how are you looking to scale this?
So we are um so we have um generally been direct to consumer. We have had uh a few deals with drug, um with pharma and food companies, very, very large companies. Uh but right now we're looking at API deals, we're trying to go B2B, we're trying to provide our experience inside other people's experiences. So we we are talking to a number of um very, very prominent apps that you use every day, literally every day, um, about how we can embed our technology into their user experience. And these are people that are you know delivering food from you know restaurants or grocery stores. These are people who are delivering um, you know, diabetes prevention, they're people who are basically providing um either chronic condition care or lifestyle or wellness kind of things. So we are our goal is to be a B2B company um and provide services inside these other experiences
that people already love and already are you know are successful. So we are world-class, best in class um technology. We're trying to connect to best in class distribution channels where people have customers, people that are showing up for some value, um, and we're trying to add to that value.
Eric Malzone: Yeah, yeah, I love it. You know, um paint me a picture of where you think this is going in like five years, right? So we're this is Q4 2024, let's just say by 2030, is AI you know starts to make things more accessible, more and that's the to me, that's the promise of artificial intelligence. It takes you know things that would cost a lot of money, makes them very accessible for many people. And then, you know, I think we're starting to look at this year, uh, you know, between what happened in the pandemic, and then I don't no need to talk politics here, but you know, with RFK Jr. now in the conversation, um, at least bringing a conversation about health and metabolic health more to the table across you know uh more of the country, it's just more in the forefront. So people are ready, right? People are starting to see that they want change. And we need change, otherwise, this company's gonna be bankrupt, this business is this uh country is gonna be bankrupt. So where where do you think you what kind of impact do you think you can make by 2030?
So yeah, so I would love to see RFK Jr. succeed in fighting big food sort of um it is everyone has tried before, no one has succeeded. I don't think that anything short of what happened before with tobacco is going to make a difference, which was really a combination of um legal action, government regulation, there was you know about transparency, about um labeling, you know, um there was there were so many things happening. If you go in and just ask ChatGPT, explain to me what happened in the sort of um anti-smoking movement, it was a combination of government, nonprofits, um, and people and like advocacy groups um that sort of sued. Um it was a combination of a lot of people. It wasn't like one or two people. There was a combination of a
lot of people and it was sustained and it was very specific and it was able to do. Unfortunately, some of those, unfortunately, uh no company can on their own start restricting themselves, you know. If companies wanted to start cutting sugar in foods or changing the type of sugar they use in food, you know, in terms of corn syrup, which is one of the worst things that you could do. I mean, uh, I could even talk about the impact this has on farms and US US farming, and it's just bad. It's bad for everybody. It's really bad. Um and you know, one out of three people has pre-diabetes. I mean, you know, you know all this because if you've been listening to things, you know that we can't even, we don't even have national readiness because not enough people can actually qualify for for armed services, you know, cer because they are you know too obese. We have our level of obesity is too high. I mean, it hits us in every it hits us in our four trillion dollar um healthcare uh industry, which is more than 80%
of it is chronic conditions, most of which is lifestyle and preventable. Um, so I mean it's kind of insanity what we do to ourselves. So I wonder, I mean, if there was going to ever be a moment where we had enough um Hotspah to do it, it would be now because you know, Donald Trump has won the popular vote, you know, the Electoral College, the Senate, the House, the Supreme Court, and like we have it all. We have all of it. So it is as close to top down as it gets, as close to China as it gets for us, right? And so we have the moment, if we wanted to, we could start um asking, for example, all-chain restaurants to label their foods. It's not very hard to do that, but you can have one milkshake that that's 1200 calories, just like that, you know, and people just don't know they're throwing in 5,000
calories, you know, 4,000 calories a day. And a lot of nutritionists will tell you it's not about calories. That's true, it's not fully about calories. Yes, sugar is your biggest um biggest culprit, but calories do matter. You you put any kind of 5,000 calories of non-sugar in your body, you're still gonna, you're it's still not gonna be good. I learned this in early days of CGM. I used to be like, oh, I don't eat sugar, and I was eating avocado and coconut, and I was getting fat like crazy because you know, fat is fat is fat. Um, and so um so if I were to have hope, I mean this would be the most hopeful moment that I would ever have for actually doing something about the US healthcare system, about the food system, which is really, really bad. We've done in the pilots that we've done with big food companies, we have shown them what their foods are doing to people because we can feed it to our digital twins, and they have seen it. They have seen, in fact, food that was created
for people with diabetes, you know, was spiking a diabetic person's blood sugar 70 points. If you're already at 180, because that's your baseline, is 180. Another 70 points, I mean, what kind of food is that? Like, why are you doing that? So, so yes, I'm very hopeful, uh, but I don't people have tried before and they were told to go sit in the corner. You know, I think Michelle Obama tried it once and it was like it was like didn't go anywhere. She was told, exercise, you know, get out and do some workout. Um, but so I think I'm I'm not hundred per I'm very optimistic. I'm super optimistic. I'm super happy about this moment because I feel like we have a shot. We have a shot, but I think we have to execute well, and we should execute with clinical evidence. We should execute with, you know, having all the voices, um, including from the industry, at the table. And I think we should do this constructively, but we should
do it fast because we're killing ourselves. In terms of what AI will do for people, I think that the more wearables uh people wear, the more prevalent wearables become. You know, I mean, Apple Watch is still being sold at an unbelievable rate. People are adopting Apple Watch even to this day. Whoop is doing a good job. Aura is thriving and is doing very, very well. Um, you know, congrats to congrats to my friends at Aura. They're doing a really, really good job. I mean, you can buy Aura at Target at CBS. It's becoming very accessible to people. People love the form factor, right? I'm wearing both of these. People love the form factor. It's four grams, it's super easy. You can sleep with it, and it's really easy. So I think the more people wear these things, the more CGMs. Dexcom and Abbott, Lingo and Stello both are coming in over-the-counter CGMs, right? The more people wear wearables, the more AI can help you because we can machine learn off of this 24-7 data
to see what is normal for you, what is baseline for you, what is a what is a thing that's bringing your pattern. We can use that data to predict, absolutely. Now, I do think that you know, those people not necessarily the people who make devices are not necessarily going to be excited about using AI to replace themselves. So I don't think they're going to be at the forefront of AI, frankly. I think they're going to be disruptors like January who are going to say, wait, we don't need to do this and this. We can already do the question is how fast can we adopt these technologies in the US healthcare system? So really the message I want to leave to really share with you is that we have the technology today. Like this is not about the future. AI is here right now, and we have AI for metabolic health. Right now we can make all Americans healthy. We can. And we have the tech. Um, it's do we have the political will? And do we have, do we really have the political will to do
it? Because we can do it, we have the tech, it's not a matter of technology. And like you and I both said, if you give people these frictionless tech, they will figure it out over time. They'll figure out, you know, I can't drink too much, I can't drink more than one, or I shouldn't drink after two o'clock. Or I should they will figure this out.
Right.
And and so for all those people who have no hope around behavior change, I have all the hope in the world around behavior change.
Eric Malzone: Awesome. Awesome. That is one hell of call to arms. I appreciate it. Um, Machine, this has been really interesting and really um positive. You know, I think it's very optimistic. So really appreciate you coming on. Um love to get you back in about a year, maybe get an update on what's going on. Um maybe we have some great news about you know the political will of the country. And uh yeah, we'll uh we'll see what happens.
That'd be amazing. That'd be amazing. I'm I'm here to help. I'm here to help. I definitely want to jump in and do whatever I can because this this is the moment.
Eric Malzone: Awesome. Ladies and gentlemen, great to meet you. Nushi and Hashemi. Thank you.
Great to see you. Bye.
Eric Malzone: Hey, wait, don't leave yet. This is your host, Eric Malzone, and I hope you enjoyed this episode of Future of Menace. If you did, I'm gonna ask you to do three simple things. It takes under five minutes and it goes such a long way. We really appreciate it. Number one, please subscribe to our show wherever you listen to it. iTunes, Spotify, Castbox, whatever it may be. Number two, please leave us a favorable review. Number three, share. Put it on social media, talk about it to your friends, send it in a text message, whatever it may be. Please share this episode because we put a lot of work into it. We want to make sure that as many people are getting value out of it as possible. Lastly, if you'd like to learn more or get in touch with me, simply go to the futureoffitness.co. You can subscribe to our newsletter there, or you can simply get in touch with me as I love to hear from our listeners. So thank you so much. This is Eric Malzone, and this is the Future of Fitness. Have a great day.
Why this conversation matters
Show notes by Dani
In this conversation, Nosheen Hashemi, CEO of January AI, discusses the revolutionary approach of integrating AI with metabolic health and nutrition. She shares her personal journey into the health tech space, the emergence of multiomics, and how January AI is transforming the way individuals understand and manage their health through data-driven insights. The conversation highlights the evolution of their product, the importance of user experience, and the potential for AI to facilitate behavior change in nutrition. Nosheen emphasizes the urgent need for health awareness and the role of technology in making health accessible to all.
Takeaways:
January AI is pioneering the integration of AI in metabolic health.
Nosheen Hashemi's background in tech and personal health challenges shaped her vision.
Multiomics allows for a comprehensive view of health beyond traditional methods.
AI can predict glucose responses without the need for continuous glucose monitors.
User experience is crucial in health tech; personalization is key.
Behavior change in nutrition is achievable with the right tools and data.
The healthcare system faces a crisis due to chronic conditions and lifestyle diseases.
Education about nutrition and health is lacking among the general public.
The future of health tech lies in making tools accessible and affordable.
AI has the potential to revolutionize how we approach health and wellness.